会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • MODULATORS OF PERIPHERAL 5-HT RECEPTORS
    • 外周5-HT受体的调节剂
    • WO2005061483A2
    • 2005-07-07
    • PCT/NO2004/000399
    • 2004-12-23
    • BIO-MEDISINSK INNOVASJON ASKLAVENESS, JoLEVY, Finn, OlavBRUDELI, Bjarne
    • KLAVENESS, JoLEVY, Finn, OlavBRUDELI, Bjarne
    • C07D401/00
    • C07D401/12A61K31/343A61K31/404A61K31/415A61K31/4184A61K31/428A61K31/445C07D209/14C07D211/22C07D211/26C07D211/58C07D405/12
    • Novel modulators of 5-HT4 receptors have been developed which have a selectivity for peripheral receptors rather than those of the central nervous systems. Theses include novel derivatives of known modulators as well as entirely novel entities. Surprisingly, the derivatised compounds of the known modulators maintain a high binding affinity to 5-HT4 receptors, despite the presence of an acidic moiety at the end of an optional chain. The entirely novel entities also exhibit good binding affinity to 5-HT4 receptors. All of the compounds of the invention have a common motif which includes a basic nitrogen moiety and an acidic moiety. The compounds of the invention, due at least in part to their high ionisation potential at physiological pH, have the unique properties of selectively for peripheral 5HT4 receptors over those of the CNS, good binding affinity, and selectively of 5HT4 receptors over other serotonin receptors.
    • 新型的5-HT 4受体调节剂已被开发出来,它们对外周受体而不是中枢神经系统的那些具有选择性。 论文包括已知调制器的新颖衍生物以及完全新颖的实体。 令人惊讶的是,尽管在任选链末端存在酸性部分,已知调节剂的衍生化合物仍维持对5-HT 4受体的高结合亲和力。 全新的实体也表现出对5-HT 4受体的良好结合亲和力。 本发明的所有化合物都具有包含碱性氮部分和酸性部分的共同基序。 本发明化合物至少部分归因于它们在生理pH下的高电离电位,对于外周5HT4受体选择性优于CNS的独特性质,具有良好的结合亲和性,并且选择性地选择性拮抗其他血清素受体上的5HT4受体。